Tocris Bioscience社 2015年5月新製品
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5519 | (-)-Pentazocine | κ-opioid agonist; antinociceptive |
| 5515 | NADPH reduced form tetrasodium salt | Cofactor for many anabolic enzymes |
| 5510 | X-Gal | Used in cloning procedures with IPTG |
| 5509 | IPTG | Used in cloning procedures with X-GAL |
| 5508 | MOPS | Widely used buffering agent |
| 5506 | Vancomycin HCl | Antibiotic |
| 5504 | D-(+)-Glucose | Naturally occurring monosaccharide |
| 5503 | Ampicillin sodium salt | Antibiotic; selection reagent |
| 5502 | Blasticidin S HCl | Antibiotic; selection reagent for bis, bsr and BSD transformed cells |
| 5487 | DPC AJ1951 | Potent parathyroid hormone (PTH) receptor agonist |
| 5480 | KRIBB11 | HSF1 inhibitor |
| 5414 | CU-T12-9 | Potent TLR1/2 activator |
| 5411 | RBC8 | RalA and RalB GTPase inhibitor |
| 5410 | TC-I 2014 | TRPM8 antagonist |
| 5304 | FICZ | High affinity aryl hydrogen receptor (AhR) agonist |
| 5293 | NK 252 | NRF2 activator |
| 5267 | OICR 9429 | High affinity and selective WDR5 antagonist |
| 5178 | ASP 7663 | Selective TRPA1 activator |
| 4957 | ML 179 | Selective inverse agonist of liver receptor homolog 1 (LRH1) |
| 4809 | DSR 6434 | Potent TLR7 agonist |
| 5560 | Obestatin (human) | Endogenous reported anorexigenic peptide |
| 5493 | XL 413 hydrochloride | Potent and selective Cdc7 inhibitor |
| 5382 | C16 | PKR inhibitor |
| 5361 | GSK LSD 1 dihydrochloride | Potent and selective LSD1 inhibitor |
| 5543 | Ropinirole - d7 | Deuterated ropinirole (Cat. No. 3680) |
| 5542 | Olanzapine - d8 | Deuterated olanzapine (Cat. No. 4349) |
| 5541 | Topiramate - d12 | Deuterated topiramate (Cat. No. 3620) |
| 5540 | Acamprosate - d6 calcium | Deuterated acamprosate (Cat. No. 3618) |
| 5539 | Miglustat - d9 hydrochloride | Deuterated miglustat (Cat. No. 3117) |
| 5538 | Risperidone - d4 | Deuterated risperidone (Cat. No. 2865) |
| 5537 | Tetrabenazine - d7 | Deuterated tetrabenazine (Cat. No. 2175) |
| 5536 | Simvastatin - d6 | Deuterated simvastatin (Cat. No. 1965) |
| 5535 | Flupirtine - d4 hydrochloride | Deuterated flupirtine (Cat. No. 2867) |
| 5534 | Citalopram - d4 hydrobromide | Deuterated citalopram (Cat. No. 1427) |
| 5533 | Metformin - d6 hydrochloride | Deuterated metformin (Cat. No. 2864) |
| 5532 | Allopregnanolone - d5 | Deuterated allopregnanolone (Cat. No. 3653) |
| 5531 | Memantine - d6 hydrochloride | Deuterated memantine (Cat. No. 0773) |
| 5530 | Clozapine - d8 | Deuterated clozapine (Cat. No. 0444) |
| 5529 | Levetiracetam - d6 | Deuterated levetiracetam (Cat. No. 2839) |
| 5528 | β-Estradiol - d3 | Deuterated β-estradiol (Cat. No. 2824) |
| 5527 | Tomoxetine - d3 hydrochloride | Deuterated tomoxetine (Cat. No. 2011) |
| 5526 | Fluoxetine - d5 hydrochloride | Deuterated fluoxetine (Cat. No. 0927) |
| 5525 | Fenretinide - d4 | Deuterated fenretinide (Cat. No. 1396) |
| 5524 | Rp-8-pCPT-cGMPS sodium | PKG inhibitor |
| 5473 | PMX 53 | Potent C5a receptor antagonist |
| 5393 | ERK5-IN-1 | Potent and selective ERK5 inhibitor |
| 5259 | WWL 113 | Ces3 and Ces1f inhibitor |
| 5088 | TC-S 7004 | Potent and selective DYRK1A/B inhibitor |
| 5544 | Donepezil - d5 hydrochloride | Deuterated donepezil (Cat. No. 4385) |
| 5013 | AC 710 | Potent and selective PDGFR family inhibitor |
| 4564 | JTV 519 fumarate | Ryanodine receptor (RyR) inhibitor |
| 5461 | Foxy 5 | Wnt5a peptide mimetic |
| 5457 | SirReal 2 | Selective inhibitor of SIRT2 |
| 5391 | SPP 86 | Potent RET inhibitor |
| 5364 | Hydroxy Dynasore | Dynamin inhibitor; analog of dynasore (Cat. No. 2897) |
| 5363 | NHI 2 | LDHA inhibitor |
| 5338 | PK-THPP | Potent TASK-3 channel blocker |
| 5330 | AEG 40730 dihydrochloride | IAP antagonist |
| 5204 | TC-E 5007 | Irreversible and selective dipeptidyl peptidase 8 and 9 (DPP-8/9) inhibitor |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
